HIGHLIGHTS
- who: Thomas Pierret from the Unit, Grenoble University Hospital, La Tronche, France, Department of Advanced Radiation have published the paper: Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases, in the Journal: (JOURNAL)
- what: The 2 prospective studies included in this analysis provided interesting details. The second study focused on by this issue is the multi-arm CheckMate 012 trial including patients with untreated, asymptomatic BM and no evidence of cerebral oedema (arm M) . The pooled analysis of Checkmate-063, Checkmate017, and Checkmate-057 trials was focused on a subgroup of patients with pretreated and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.